Ubs Oconnor LLC Agios Pharmaceuticals, Inc. Call Options Transaction History

Ubs Oconnor LLC

  • $1.46 Billion
  • Q3 2024

Call Options

4 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q3 2024

Nov 14, 2024
SELL
$41.19 - $49.72 $1.03 Million - $1.24 Million
-25,000 Reduced 55.56%
20,000 $888,000
Q2 2024

Aug 14, 2024
BUY
$27.55 - $48.83 $137,750 - $244,150
5,000 Added 12.5%
45,000 $1.94 Million
Q1 2024

May 15, 2024
BUY
$21.32 - $34.81 $852,800 - $1.39 Million
40,000 New
40,000 $1.17 Million
Q2 2023

Aug 14, 2023
BUY
$21.38 - $29.19 $1.07 Million - $1.46 Million
50,000 New
50,000 $23.8 Million

Others Institutions Holding AGIO

# of Institutions
232
Shares Held
58.1M
Call Options Held
403K
Put Options Held
469K
View Full List

About AGIOS PHARMACEUTICALS, INC.

AGIO Quotes by TradingView
  • Ticker AGIO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 54,818,000
  • Market Cap $3.24B
  • Description
  • Agios Pharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery and development of medicines in the field of cellular metabolism and adjacent areas of biology. The company offers PYRUKYND (mitapivat) an activator of both wild-type and a variety of mutant pyruvate kinase, PK, enzymes for the treatment of hemolytic anemias; and ...
More about AGIO
Track This Portfolio

Track Ubs Oconnor LLC Portfolio

Follow Ubs Oconnor LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ubs Oconnor LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ubs Oconnor LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email